期刊
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
卷 280, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.resp.2020.103492
关键词
COVID-19; SARS-COV-2; Inflammation; Steroids; Dexamethasone
资金
- Carlos Chagas Filho Rio de Janeiro State Research Foundation, Rio de Janeiro, Brazil
- Brazilian Council for Scientific and Technological Development (CNPq), Brasilia, Brazil
- Coordination for the Improvement of Higher Education Personnel (CAPES), Brasilia, Brazil
- Department of Science and Technology (DECIT) - Brazilian Ministry of Health
- National Institute of Science and Technology for Regenerative Medicine
In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In this short communication, we will evaluate the use of corticosteroids as an adjunctive pharmacological therapy in the management of COVID-19 and describe its pros and cons in light of the latest available evidence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据